Loading clinical trials...
Loading clinical trials...
This blinded, placebo-controlled study will administer inhaled nitric oxide to patients undergoing liver transplantation. The purpose of the study is to test if inhaled nitric oxide prevents liver inj...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Alabama at Birmingham
Collaborators
NCT04937868 · Abdominal Injury, Pelvic Fracture, and more
NCT07128108 · Chronic Liver Injury, Mindray Hepatus 9 Ultrasound Diagnostic System
NCT07050550 · Liver Injury
NCT04630535 · Obstructive Sleep Apnea, Vascular Aneurysm, and more
NCT05004610 · Cardiac Arrest, Ischemia Reperfusion Injury, and more
University of Alabama at Birmingham
Birmingham, Alabama
University of Washington
Seattle, Washington
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions